The present invention relates to novel salts of 4 {[4 ({[4 (2 2 2 trifluoroethoxy) 1 2 benzisoxazol 3 yl]oxy}methyl)piperidin 1 yl]methyl}tetrahydro 2H pyran 4 carboxylic acid. More particularly the invention relates to salt forms (HCl salt HBr salt p toluenesulfonate salt and ethanedisulfonate salt) and to processes for the preparation of compositions containing and to uses of such salt forms.